section name header

Y-Site Injection Compatibility (1:1 Mixture)

Blinatumomab

(Mfr: AMG)(Conc: 0.125 mcg/mLb)

QMark

Tranexamic acid

(Mfr: SAA)(Conc: 100 mg/mL)

Remarks:

Haze or flakes transiently appear

Ref:

3405,3417